TCT 465: PROTEMBO C-TRIAL: Evaluation of a Novel Cerebral Embolic Protection Device in TAVR
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Medtronic; Microport
- Grant Support/Research Contract - Boston Scientific Corporation